Konstantinov B A, Eramishantsev A K, Goté S V, Tsirulńikova O M, Skipenko O G, Lebezev V M, Shertsinger A G, Lokshin L S
Khirurgiia (Mosk). 1993 Mar(3):32-44.
The article deals with the results of work conducted according to the orthotopic liver transplantation (OLT) program from January 1990 to January 1992. To select the patients for OLT, 54 persons (24 males and 30 females aged from 12 to 55 years) with diffuse (34) and focal (20) diseases of the liver were examined. OLT was indicated for 19 patients who were registered in the waiting list. In the period of waiting for the donor organs, 5 persons died, 3 refused to undergo OLT, and 4 remain on the waiting list. Eight OLT (including one retransplantation) were conducted on 7 patients. The indications for OLT in these patients were: unresectable hepatocellular carcinoma (4), cirrhosis of the liver of viral etiology (1), fulgurant form of hepatitis B (1), transplant rejection crisis which could not be arrested (1). Immunosuppression was conducted by the two- and three-component programs with the use of corticosteroids, cyclosporine A, and azathioprine. Eight crises of transplant rejection were encountered, successful retransplantation of the liver was accomplished for one of two crises which could not be arrested. The survival of the operated on recipients ranged from 3 days to 15 months. Various complications (mainly hemorrhagic and infectious) were encountered in the posttransplantation period. At the time that the article is written, 3 patients are living for 15, 9, and 4 months (after retransplantation of the liver in the last case), their condition is satisfactory. The death of the other recipients was caused by candidosepsis (on the 40th day), polyorganic insufficiency (on the 10th and 3rd days), sepsis (on the 12th day). The results of the liver transplantation program correspond to those of transplantation centers in other countries in the period of OLT mastering.
本文论述了1990年1月至1992年1月按照原位肝移植(OLT)计划开展工作的结果。为选择OLT患者,对54例(24例男性和30例女性,年龄12至55岁)患有弥漫性(34例)和局灶性(20例)肝脏疾病的患者进行了检查。有19例患者登记在等待名单上,符合OLT指征。在等待供体器官期间,5人死亡,3人拒绝接受OLT,4人仍在等待名单上。对7例患者进行了8次OLT(包括1例再次移植)。这些患者接受OLT的指征为:无法切除的肝细胞癌(4例)、病毒性病因的肝硬化(1例)、暴发性乙型肝炎(1例)、无法控制的移植排斥危机(1例)。采用含皮质类固醇、环孢素A和硫唑嘌呤的二联和三联方案进行免疫抑制。共发生8次移植排斥危机,在2次无法控制的危机中,有1次成功进行了肝脏再次移植。接受手术的受者存活时间为3天至15个月。移植后出现了各种并发症(主要是出血性和感染性并发症)。在撰写本文时,3例患者分别存活了15个月、9个月和4个月(最后1例为肝脏再次移植后),他们的情况良好。其他受者的死亡原因分别是念珠菌败血症(第40天)、多器官功能不全(第10天和第3天)、败血症(第12天)。在OLT技术掌握阶段,该肝移植计划的结果与其他国家移植中心的结果相符。